The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to AmerisourceBergen Drug Corporation for the supply of 4,565,828,590 units of the pharmaceutical product Bydureon BCISE 2 mg AutoInject 0.85 mL. The contract has a ceiling value of $1,570.20 and is a Firm Fixed Price contract. The award date was September 16, 2024, and the ultimate completion date is September 17, 2024. AmerisourceBergen Drug Corporation is a major supplier of pharmaceutical products and medical supplies to the federal government, supporting various military treatment facilities and healthcare programs. This contract award is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities. There is no set-aside designation mentioned for this specific award.
Generated 12/16/24, 2:26 PM